Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Prime Medicine (PRME) Amortization - Intangibles (2023 - 2025)

Prime Medicine filings provide 3 years of Amortization - Intangibles readings, the most recent being $858000.0 for Q4 2025.

  • On a quarterly basis, Amortization - Intangibles rose 180.39% to $858000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $2.5 million, a 29.31% decrease, with the full-year FY2025 number at $2.5 million, down 29.31% from a year prior.
  • Amortization - Intangibles hit $858000.0 in Q4 2025 for Prime Medicine, up from $752000.0 in the prior quarter.
  • In the past five years, Amortization - Intangibles ranged from a high of $2.0 million in Q2 2023 to a low of $306000.0 in Q4 2024.
  • Median Amortization - Intangibles over the past 3 years was $858000.0 (2025), compared with a mean of $985909.1.
  • Biggest five-year swings in Amortization - Intangibles: tumbled 72.82% in 2024 and later skyrocketed 180.39% in 2025.
  • Prime Medicine's Amortization - Intangibles stood at $1.1 million in 2023, then tumbled by 72.82% to $306000.0 in 2024, then surged by 180.39% to $858000.0 in 2025.
  • The last three reported values for Amortization - Intangibles were $858000.0 (Q4 2025), $752000.0 (Q3 2025), and $530000.0 (Q2 2025) per Business Quant data.